Chemoembolization for primary and metastatic liver cancer.
about
Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model.Transcatheter arterial chemoembolization: history for more than 30 years.Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer.Pattern of retained contrast on immediate postprocedure computed tomography (CT) after particle embolization of liver tumors predicts subsequent treatment response.Repeated hepatic resections and radio-frequency ablations may improve the survival of adult undifferentiated embryonal sarcoma of the liver: report of two cases.Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol.Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility studyEfficacy and safety of percutaneous microwave coagulation therapy followed by (125)I seed brachytherapy for VX2 hepatic tumors in a rabbit model.Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature.Multi-modality curative treatment of salivary gland cancer liver metastases with drug-eluting bead chemoembolization, radiofrequency ablation, and surgical resection: a case reportThe effect of transcatheter arterial chemoembolization on hepatitis C viremia.Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
P2860
Q34279653-40BD344B-B676-450C-9A46-EB943E465A34Q34642418-9E10EF8B-8416-427C-83F1-9F77BAF5FA34Q35042291-DDC69A4A-6BF6-40B5-BD30-376E66493B41Q35383390-219D59F2-3160-49F5-BFE8-C0F33E2C2261Q36028082-8D2568AB-7B31-4668-9C2E-96CCCFBD3C77Q36310445-F234FC89-3F65-4A12-923E-F51336AFD0ADQ37075313-B3310332-030E-4E2B-8C72-EB9635D761BBQ37075561-A0C0E758-6A1B-47F5-B20B-F31F84446633Q38192781-40313503-5BFC-48EE-87D6-838EC4F3FF86Q38367237-C04F870D-E962-43FD-8AC1-61A40F7C72DFQ42326706-68955BF1-906A-4297-9694-CFFB2514CFCCQ50890846-12F7F068-0CC2-42B7-8E56-08034A15E4FAQ59135179-512F9034-046E-4A5D-B1F0-099AC94D5D34
P2860
Chemoembolization for primary and metastatic liver cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemoembolization for primary and metastatic liver cancer.
@en
Chemoembolization for primary and metastatic liver cancer.
@nl
type
label
Chemoembolization for primary and metastatic liver cancer.
@en
Chemoembolization for primary and metastatic liver cancer.
@nl
prefLabel
Chemoembolization for primary and metastatic liver cancer.
@en
Chemoembolization for primary and metastatic liver cancer.
@nl
P1433
P1476
Chemoembolization for primary and metastatic liver cancer
@en
P2093
Jean-Francois H Geschwind
P304
P356
10.1097/PPO.0B013E3181D7E905
P50
P577
2010-03-01T00:00:00Z